Vidofludimus
| CAS No. | 717824-30-1 | Cat. No. | BCP14555 |
| Name | Vidofludimus | ||
| Synonyms | 4SC 101; 4SC-101; 4SC101; SC12267; SC-12267; SC 12267; | ||
| Formula | C20H18FNO4 | M. Wt | 355.36 |
| Description | Vidofludimus, also known as 4SC 101 or SC12267, is a novel orally active and potent DHODH inhibitor. In vitro, 4SC-101 is a potent inhibitor of human DHODH, inhibits lymphocyte proliferation, and uniquely blocks phytohemagglutinin-stimulated IL-17 production by lymphocytes. In vivo, oral administration of 4SC-101 effectively improved both chronic DSS and acute TNBS colitis in mice. 4SC-101 may have potential for the treatment of intestinal inflammation. Dihydroorotate dehydrogenase (DHODH) is a key enzyme involved in pyrimidine biosynthesis. DHODH is a known target for the treatment of autoimmune diseases. | ||
| Pathways | Others Pathway | ||
| Targets | Interleukin Related | ||
Structure
Part data of this page collected from the open network resources, so Biochempartner can not guarantee its accuracy.
For product details of different batches, please contact our Customer
- Service & Tech Support:orders@biochempartner.com
- Website:www.biochempartner.com
Products are for research use only and not for human use. We do not sell to patients.